Table 4.

Malaria prevalence (by LM and PCR) by study site

	Lupuna (LUP)				Cahuide (CAH)				Total
	n	%	% [95% CI]		n	%	% [95% CI]		n	%	% [95% CI]
Microscopy
Total analysed samples (N)	829				1112				1941
P. vivax*	8	1.0	0.4	2.0	30	2.7	1.9	3.9	38	2.0	1.4	2.7
P. falciparum	2	0.2	0.0	1.0	0	0.0			2	0.1	0.0	0.4
Overall*	10	1.2	0.6	2.3	30	2.7	1.9	3.9	40	2.1	1.5	2.8
Asymptomatic P. vivax	3	0.4	0.1	1.1	24	2.2	1.4	3.2	27	1.4	0.9	2.0
Symptomatic P. vivax	5	0.6	0.2	1.5	6	0.5	0.2	1.2	11	0.6	0.3	1.0
Asymptomatic P. falciparum	1	0.1	0.0	0.8	0	0.0			1	0.1	0.0	0.3
Symptomatic P. falciparum	1	0.1	0.0	0.8	0	0.0			1	0.1	0.0	0.3
PCR
Total analysed samples (N)	777				1013				1790
P. vivax*	30	3.9	2.7	5.5	63	6.2	4.8	7.9	93	5.2	4.2	6.4
P. falciparum*	9	1.2	0.6	2.3	26	2.6	1.7	3.8	35	2.0	1.4	2.7
Overall*	39	5.0	3.6	6.9	89	8.8	7.2	10.7	128	7.2	6.0	8.5
Asymptomatic P. vivax	20	2.6	1.6	4.0	53	5.2	4.0	6.8	73	4.1	3.2	5.1
Symptomatic P. vivax	10	1.3	0.7	2.4	10	1.0	0.5	1.9	20	1.1	0.7	1.8
Asymptomatic P. falciparum	5	0.6	0.2	1.6	23	2.3	1.5	3.4	28	1.6	1.1	2.3
Symptomatic P. falciparum	4	0.5	0.2	1.4	3	0.3	0.1	0.9	7	0.4	0.2	0.8
Sub-patent P. vivax	22	2.8	1.8	4.3	41	4.0	3.0	5.5	63	3.5	2.7	4.5
Patent P. vivax	8	1.0	0.5	2.1	22	2.2	1.4	3.3	30	1.7	1.2	2.4
Sub-patent P. falciparum	8	1.0	0.5	2.1	26	2.6	1.7	3.8	34	1.9	1.3	2.7
Patent P. falciparum	1	0.1	0.0	0.8	0	0.0			1	0.1	0.0	0.4

* Significant difference between sites (p < 0.05)